About this item:

147 Views | 72 Downloads

Author Notes:

Gregory S. Day, MD, MSc, Charles F. and Joanne Knight Alzheimer Disease Research Center, Washington University School of Medicine in St Louis, 4488 Forest Park Ave, Ste 160, St Louis, MO 63108 (gday@wustl.edu)

Dr Day had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.

Concept and design: Day.

Acquisition, analysis, or interpretation of data: All authors.

Drafting of the manuscript: Day, Coble.

Critical revision of the manuscript for important intellectual content: Day, Cruchaga, Wingo, Schindler, Morris.

Statistical analysis: Day, Cruchaga, Schindler, Coble.

Obtained funding: Day, Cruchaga, Morris.

Administrative, technical, or material support: Day.

Supervision: Morris.

Chengjie Xiong, PhD, and Elizabeth Grant, PhD (Knight ADRC Biostatistics Core, Washington University School of Medicine in St Louis), provided assistance with data management.

Tammie L. S Benzinger, MD, PhD (Department of Radiology, Washington University School of Medicine in St Louis), and colleagues in the Knight ADRC Imaging Core and Anne Fagan, PhD (Department of Neurology, Washington University School of Medicine in St Louis), and colleagues in the Knight ADRC Biomarker Core provided supporting imaging and cerebrospinal fluid biomarker measures in study participants.

Dr Day reported receiving grants from the National Institutes of Health (NIH), National Institute on Aging (NIA), and Knight Alzheimer Disease Research Center (ADRC); salary support from Barnes Jewish Hospital; nonfinancial support from Avid Radiopharmaceuticals; holding stocks in ANI Pharmaceuticals; and serving as topic editor for DynaMed.

Dr Cruchaga reported receiving research support from Biogen, Eisai, Alector, and Parabon NanoLabs and serving as a member of the advisory boards of Vivid Genomics, Halia Therapeutics, and ADx Healthcare.

Dr Wingo reported receiving grants from the US Department of Veterans Affairs, NIA and Parabon NanoLabs (via a subaward from the NIH).

Dr Morris reported receiving grants from NIH during the conduct of the study.

No other disclosures were reported.

Subjects:

Research Funding:

Study funding was provided through a grant paid to Knight ADRC (P50 AG05681) from NIA with additional support from grants from NIH (P01AG003991 and P01AG026276).

Keywords:

  • acquired factors
  • heritable factors
  • genetics
  • intergenerational difference
  • age at symptomatic onset
  • Alzheimer disease
  • family history
  • dementia
  • early onset

Association of Acquired and Heritable Factors With Intergenerational Differences in Age at Symptomatic Onset of Alzheimer Disease Between Offspring and Parents With Dementia

Tools:

Journal Title:

JAMA Network Open

Volume:

Volume 2, Number 10

Publisher:

Type of Work:

Article | Final Publisher PDF

Abstract:

Question What are the associations of acquired and heritable factors with intergenerational differences in age at symptomatic onset (AAO) of Alzheimer disease (AD) among offspring of parents with AD? Findings In this cohort study including 164 participants with symptomatic AD and a parental history of dementia, the factors of parental inheritance, more years of education, and retrospective determination of AAO were associated with an earlier-than-expected AAO of AD; parental history of early-onset dementia, APOE ε4 allele status, and hypertension were associated with a later-than-expected AAO of AD. Missense or frameshift variants within genes associated with AD pathogenesis were more common in participants with greater unexplained variability in intergenerational AAO of AD. Meaning Acquired and heritable factors were associated with a substantial proportion of variability in intergenerational AAO of AD.

Copyright information:

2019 Day GS et al. JAMA Network Open.

This is an Open Access work distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/).
Export to EndNote